Call in the doctor

29 November 2005 By Rob Cox

The drug company is acquiring its parent in a deal its billionaire founder says was negotiated at arm’s length. But that s not reflected in the valuation placed on the main asset being acquired. Sometimes it hurts to be a minority investor in the US.

This content is for Subscribers only

To access full content you must be a subscriber. Please use the following link to request a trial.


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)